Aml3D Limited

AL3

AML3D Ltd. engages in the provision of 3D printing services and machinery. The company is disrupting metal part supply chains using the Company’s patented Wire Additive Manufacturing (WAM) process. WAM combines welding science, robotics automation, materials engineering and proprietary software to lead metal additive manufacturing globally. The company is the original equipment manufacturer (OEM) of the ARCEMY industrial metal 3D printing systems. ARCEMY uses WAM to provide advanced, automated, on-demand, point-of-need 3D manufacturing solutions that are more efficient, cost-effective and have ESG outcomes compared to traditional casting, forging and billet machining processes. ARCEMY is the Internet of Things (IoT) and Industry 4.0 enabled to allow manufacturers across aerospace, defense, maritime, manufacturing, mining and oil & gas to become globally competitive. The company also provides metal 3D printing design engineering services, software licensing, technical support, consumable sales and contract manufacturing services.

Green Critical Minerals Limited

GCM

Green Critical Minerals Ltd. engages in the exploration and acquisition of mineral properties. The company is headquartered in Subiaco, Western Australia. The company went IPO on 2007-11-15. The firm's projects include McIntosh - Graphite, Red Fox Resources - Base Metal, Hawkwood - nickel-copper-platinum group elements (Ni-Cu-PGE), North Barkly Project - Rare Earths and Torrington - Tungsten and Topaz. The firm holds earn-in rights for up to 80% of the advanced High Quality McIntosh Graphite Project. The company holds an approximately 30.4% interest in Red Fox Resources Pty Ltd (Red Fox). The North Barkly Project is comprised of three Exploration License applications (33128/29/30) totaling approximately 1,950 square kilometers (sq km) over pastoral lands on the Barkly tablelands 500 kilometers (km) northwest of Mount Isa and 150 km southwest of McArthur River. The Boulia project area is comprised of two EPM applications - Canary (EPMA 28251) and Prickly Bush (EPMA 28253). The firm has an advanced Topaz-Tungsten project near Torrington, 60 km SSW of Tenterfield.

Botanix Pharmaceuticals Ltd

BOT

Botanix Pharmaceuticals Ltd. is a dermatology company, which engages in the provision of business of researching and developing dermatology and antimicrobial products. The company is headquartered in Perth, Western Australia. The Company’s lead product is Sofdra (sofpironium) topical gel, 12.45%, a prescription anticholinergic medicine used on the skin (topical), to treat excessive underarm sweating (primary axillary hyperhidrosis) in adults and children nine years of age and older. Sofdra regulates sweating at the site of application, by binding to the primary sweat receptor and thereby blocking the sweat signal. Its product pipeline targets the various skin diseases, such as BTX 1503 for Acne, BTX 1702 for Rosacea, BTX 1204A for Atopic Dermatitis, and BTX 1801 for Hemodialysis Patients. Its BTX 1503 is a transdermal gel formulation for the treatment of serious acne in adults and teenagers. BTX 1702 is used for the treatment of papulopustular rosacea. BTX 1801 is an antimicrobial gel focused on targeting Staphylococcus Aureus and Methicillin Resistant Staphylococcus Aureus (MRSA).

Vanguard MSCI Index International Shares ETF

VGS

VGS.AX was created on 2014-11-18 by Vanguard. The fund's investment portfolio concentrates primarily on total market equity. Vanguard MSCI International Shares Index ETF seeks to track the return of the MSCI World ex-Australia Index (with net dividends reinvested) in Australian dollars before taking into account fees, expenses and tax.

VanEck Morningstar Wide Moat ETF

MOAT

MOAT.AX was created on 2015-06-26 by VanEck. The fund's investment portfolio concentrates primarily on total market equity. The VanEck Morningstar Wide Moat ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Morningstar Wide Moat Focus Index.